Yahoo Finance Live anchors discuss reports that Apple has ditched plans to increase iPhone 14 production.
Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
Yahoo Finance Live anchors discuss Biogen stock performance on promising Alzheimer’s drug trial data.
Yahoo Finance's Allie Garfinkle discusses news that Apple has asked suppliers to pull back production by up to 6 million units and what it signals about consumer demand ahead of the holiday season.
Boyar Research's Jonathan Boyar joins Yahoo Finance Live to discuss low stock valuations, the stock market, and his stock picks in the financial and tech sectors.
In this article, we will be taking a look at the 10 companies that are buying back their stock in 2022. To skip our detailed analysis of these companies, you can go directly to see the 5 Companies that are Buying Back Their Stock in 2022. So far in 2022, we have seen a number of […]
Yahoo Finance's Jared Blikre breaks down how stocks are trading after a huge move in bond yields after the Bank of England announced it would buy UK bonds.
The benchmark S&P 500, which is typically viewed as the best barometer of stock market health, produced its worst first-half return in 52 years. As for the growth-driven Nasdaq Composite, an index largely responsible for pushing the stock market to new highs, it's lost about a third of its value. This puts both the S&P 500 and Nasdaq firmly in a bear market.
Creating reliable streams of retirement income is one of the most important elements of a person's financial plan. A retirement industry giant says it now has a new way for retirees to meet this vital challenge. Fidelity Investments plans to … Continue reading → The post There's a New Way to Convert Your 401(k) into a Pension-like Stream of Income appeared first on SmartAsset Blog.
The Dow Jones Industrial Average rose Wednesday, ahead of Fed chief Powell's speech, struggling to avoid a seventh straight decline.
In this article, we will discuss the 10 dividend paying stocks you should avoid according to Morgan Stanley’s quant screen. If you want to read about similar stocks, you can also take a look at 5 Dividend Paying Stocks You Should Avoid According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Sherry Paul: “It’s a Buying […]
In this article, we discuss 11 best dividend aristocrat stocks to buy heading into recession. If you want to see more stocks in this selection, click 5 Best Dividend Aristocrat Stocks To Buy Heading Into Recession. Several of the world’s biggest economies face increasing recession risks as a result of the skyrocketing inflation and the […]
Biogen stock rips higher on a promising new drug. Here's what Wall Street is saying.
Mind Medicine (MindMed) Inc. ("MindMed") (NASDAQ: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced the pricing of its underwritten public offering of 7,058,823 common shares, together with accompanying warrants to purchase 7,058,823 common shares. The combined offering price to the public of each common share and accompanying warrant is $4.25. Each common share will be sold in combination with an accompanying
Analysts are either optimistic or delusional. But either way, they see a big S&P 500 29% rally coming — and have picked favorite stocks.
In this article, we will discuss the 10 dividend paying stocks to buy according to Morgan Stanley’s quant screen. If you want to explore similar stocks, you can also take a look at 5 Best Dividend Stocks to Buy According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Base Case: S&P Falling to $3,400 by Year […]
The CBOE Volatility Index has skyrocketed 89% so far this year. Morningstar put together a list of stocks with one- and three-year betas of 0.8 or lower. Then it screened for stocks that are undervalued, according to Morningstar analysts' fair value estimates.
For many retail investors, the events of late January 2021 will go down in legend. The year 2020 could be characterized as the rise of the retail investor. Amid the retail revolution, one voice rose to the top.
Biogen stock catapulted Wednesday — bringing shares of other Alzheimer's plays with it — after its experimental treatment succeeded in a test.
Shares of Atlis Motor Vehicles surged Tuesday after making their debut on the Nasdaq Stock Market. Atlis Motor (ticker: AMV) is an Arizona-based producer of EV batteries and work trucks. The company was founded in 2016 by Chief Executive Mark Hanchett.